Prevention of Person-to-Person COVID Transmission
(Katie's Clinical Jazz)
Pediatric Fluid Management
Migraines
COVID Clinical Update
Healthcare Improvement
(Mitch's Grand Rounds)
100

In addition to social distancing and wearing of masks, this is the third primary method of person-to-person transmission prevention covered by a recent meta-analysis published by Lancet.  

Protective eye-wear

100

The percent dehydration estimate for a 6 month old infant based on clinical findings of dry buccal mucous membranes, tachycardia, little or no urine output for past 12 hours, lethargy, sunken eyes and fontanelles, loss of skin turgor

10%

100

The amount of time that the neurolgic symptoms that precede migraines with aura typically take to completely resolve.  

60 mins ("1 hour" is also an acceptable answer)

100

The 2020 Chest recommendations suggest that hospitalized patients with COVID seem to have a risk of VTE >1% and thus should probably all receive this dose level of anticoagulation.

Prophylactic anticoagulation

100

The broad term for information exchange through technology remotely to improve a person's health. 

Telehealth

200

This type of mask is thought to be associated with a larger reduction of transmission risk when compared with surgical or similar masks.

N95 Respirators

200

Fluid used for initial volume resuscitation of a 10 % dehydrated infant

Normal saline

200

The OTC combination that is considered an effective first line abortive treatment for migraines.

Aspirin-caffeine-acetaminophen

200

This is the agent found in the RECOVERY trial to have a NNT of 36 for mortality in hospitalized patients with COVID-19

Dexamethasone

200

This document is a requirement of all affordable care organizations under the ACA, and must be updated and disseminated every three years.

Community Health Needs Assessment

300

The age at which people are recommended to begin wearing masks while in public, according to the CDC.

2

300

The default set of clinical pathways used by the CH Pediatric Hospitalists

Seattle Children's

300

The criterion symptom distinguishing a hemiplegic migraine from other, more common forms of the disorder.  

Unilateral weakness

300

The agent recommended by the September 2020 Chest recommendations for anticoagulation in most hospitalized COVID-19 patients, excluding those with massive PE or at high risk for massive PE

Low molecular weight heparin

300

Alongside cost, availability, and health literacy, this was identified as a major barrier to healthcare access in the NH Capital Region by a 2018 review.

Transportation

400

According to the CDC, protective face masks are not a substitute for this.

Social distancing

400

The composition of initial maintenance IV fluid for a 7-yo admitted for abdominal pain with normal electrolytes and who urinated after receipt of fluid bolus in ED

D5NS with 20meqKCl/l

400

Of the three most effective triptans for management of migraine pain, this has the fastest half-life, making rebound headaches more likely.

Rizatripan (or Maxalt)

400

The subgroup of patients given dexamethasone in which there was a trend towards increased mortality in the RECOVERY trial

Those not receiving oxygen supplementation

400

This notable telehealth intervention/modality was excluded from research on telehealth evidence mapping in 2016, making its effectiveness comparatively understudied.

Telephonic (or Telephone) 

500

The adjusted odds ratio of contracting COVID when socially distant (> 1 meter) compared to when not.

82% less

(77-87)

500

Composition of initial maintenance IV fluid for 34 week infant on CPAP

D10W

500

These medications and starting doses to prescribe in order to best approximate the therapeutic effects of the effective (but prohibitively expensive, at $910/9 tabs) of Treximet.

Sumatriptan 50mg / Naproxen 500mg

500

The number of days that remdesivir was found to decrease time to recovery in hospitalized patients with COVID-19, which was the primary outcome in the ACTT-1 trial.


4 (remdesivir time to recovery = 11 days; placebo = 15)

500

This organization is the federal healthcare quality improvement agency in the United States

Agency for Healthcare Research and Quality.

M
e
n
u